Melinda Taschetta-Millane, Editorial Director
Melinda Taschetta-Millane, Editorial Director
Blog | Melinda Taschetta-Millane, Editorial Director | Breast Imaging| October 03, 2018

Increased Awareness Teamed With Advanced Technology Saves Lives

About 40,920 women in the U.S. are expected to die from breast cancer this year

According to BreastCancer.org, an estimated 266,120 new cases of invasive breast cancer are expected to be diagnosed in the U.S. in 2018, along with 63,960 new cases of in situ breast cancer. About 1 in 8 U.S. women — around 12.4 percent — will develop invasive breast cancer over the course of her lifetime. About 40,920 women in the U.S. are expected to die from breast cancer this year, although death rates have been decreasing since 1989, with women under 50 experiencing larger decreases. Undoubtedly the stressed importance of early detection, increased awareness of breast density, and both treatment and technology advancements have played a large role in this slow but steady decline.

Breast imaging technologies have evolved fairly rapidly over the past two decades to help physicians detect breast cancers at an earlier stage. Clinical studies have proven the effectiveness of newer technologies such as automated breast ultrasound (ABUS), digital breast tomosynthesis (DBT) and breast magnetic resonance imaging (MRI) in finding more cancers that traditional mammograms might miss, as well as interval cancers that develop between screenings.

While the benefits of these and other supplemental screening methods have been demonstrated, a multimodality approach is not necessarily the best one for every woman. “It’s not a one-size-fits-all, it never has been in a lot of ways,” said Karen Hou, M.D., diagnostic radiologist at Northwestern Medicine Central DuPage Hospital (CDH) in Winfield, Ill., in the itnTV video “Breast Imaging and Risk Assessment at Northwestern Medicine Central DuPage.” To ensure that every woman gets the appropriate level of care she deserves, Hou and her colleagues at the CDH Breast Health Center opened the CDH High-Risk Breast Clinic in 2017.

In the video, Hou discusses ways to best implement the various breast screening technologies to serve your patient base. “You have to look at how you want it to fit your workflow, and make a decision on what you are going to use as a screening tool and what you are going to use to make a diagnostic decision. You want to be applying the technology in the most appropriate way so that patients will benefit the most,” she stated. “What we’ve done is try to use some kind of logic of what is accessible for people and what we could do to best serve them. It’s not a one-size-fits-all, it never has been in a lot of ways. It’s a lot of personalized customization of what is best for each individual’s care.”

Northwestern Medicine’s high-risk program entails its team trying to identify the high-risk individuals based on family and personal risk factors. “There are individuals who should not just have a mammogram once a year or every other year, and there are certain individuals who really should have more intense screening, and most importantly education and counseling,” Hou explained. “We have a high-risk clinic where people can get assessed, and they can sit down with somebody to really just discuss their personal level of risk and what they should be doing — it’s lifestyle, it’s having an understanding of what the reality is. We have identified early cancers in individuals who have been screened and would have otherwise been unsuspected. Here, we wanted to make it an established part of our program that is easily accessible.”

You can watch the video featuring Hou at https://bit.ly/2xCd2eT. To read more about advanced breast imaging technologies in this issue, see “The Evolution of Digital Breast Tomosynthesis” on page 28, and “Practicing Patient-Centered Mammography” on page 30.

 

Augmented Content

We continue our enhanced coverage of the industry through Blippar content. It’s an innovative way for you to view expanded content in several of our features in each issue. This issue, our augmented print campaign begins on page 17, where you can watch the VIDEO “Examples of Artificial Intelligence in Medical Imaging Diagnostics.” For additional breast imaging information, watch the VIDEO roundtable discussion, “Stereotactic Breast Biopsy Procedures: A Roundtable Discussion With the Cleveland Clinic.” And for more information on women’s health issues and breast density, watch the VIDEOS: “Breast Imaging and Risk Assessment at Northwestern Medicine Central DuPage,” “The Impact of Breast Density Technology and Legislation” and “Developments in Breast Density Legislation and Screening Guidelines.”

Related Content

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...
Therapixel Appoints Matthieu Leclerc-Chalvet as CEO
News | Artificial Intelligence | July 03, 2019
Artificial intelligence (AI) breast cancer screening specialist Therapixel announced the appointment of Matthieu...
GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

Feature | Breast Imaging | July 03, 2019 | By Greg Freiherr
Productivity and its enabler — efficiency — guided the display of products at the April...
Countless possibilities can impact the future of global healthcare and AI is the first step toward breakthrough that will change the landscape of personalized medicine
Feature | Women's Health | July 03, 2019 | By Samir Parikh
Contrary to what many people believe,...

Image courtesy of GE Healthcare

Feature | Radiology Business | July 03, 2019 | By Jeffrey Hoffmeister, M.D.
Burnout in the medical profession is not uncommon, particularly as clinicians have become more overwhelmed by growing
iCAD ProFound AI

Image courtesy of iCAD

News | Breast Imaging | June 25, 2019
Use of...